V

Vaccitech

47 employees

Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Pharmaceutical
Non-small cell lung cancer
Vaccines
Prostate cancer
Research
Viral vectors
Oncology
HPV
Infectious Disease
Therapeutics
Immunotherapy
HBV
Medical

Date founded

2016

Funding rounds raised

Total raised

$168M

from 12 investors over 12 rounds

V

Vaccitech raised $168M on March 17, 2021

Investors: Oxford Sciences Innovation, Gilead Sciences, Tencent, M&G and Future Planet Capital

V

Vaccitech raised undisclosed on November 1, 2020

Investors: Future Planet Capital

V

Vaccitech raised $7.6M on December 20, 2018

Investors: Genematrix and Korea Investment Partners

V

Vaccitech raised $28M on January 15, 2018

Investors: Oxford Sciences Innovation, Xfund and GV

V

Vaccitech raised $12M on November 8, 2016

Investors: Oxford Sciences Innovation

FAQ